60 Degrees Pharmaceuticals, Inc. Warrant

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapies for the prevention and treatment of infectious diseases. It offers Arakoda for malaria prevention. The company is also developing Tafenoquine (Arakoda regimen), which is in a Phase IIb clinical trial for COVID-19, as well as Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases, and Celgosivir for respiratory viruses and dengue. Founded in 2010, the company is based in Washington, District of Columbia.